X hits on this document

PDF document

TREAT-NMD/NIH International Conference - page 2 / 4





2 / 4

research and therapy. It aims at promoting exchanges between the scientists of the two fields and beyond, at stimulating the emergence of new research projects at the interface between disciplines and at training young researchers in this interdisciplinary field. For further details

International Conference on Myasthenia

Date: 1-2 December 2009 Venue: Paris, France The conference will bring together research scientists and clinicians from around the world who specialise in myasthenia, to review the latest developments, exchange experiences and ideas, and broaden knowledge and understanding of this rare disease. A session dedicated to the interaction between clinicians, scientists, and patient associations is also scheduled. For further details

Meeting of the International Society of Neonatal Screening and Latin American Society of Inborn Errors of Metabolism

Date: 6-9 December 2009 Venue: Cancun, Mexico For the first time the International Society of Neonatal Screening and the Latin American Society of Inborn Errors of Metabolism join forces to host the seventh International and Latin American Congress on Inborn Errors of Metabolism and Neonatal Screening, an academic event aimed to foster the interchange of new ideas and experiences in the fields of inborn metabolic diseases and neonatal screening. For further details

2010 Neuromuscular Disorders Conference: Toward a Better Future

Date: 26-27 February 2010 Venue: Sydney, Australia Featuring a stimulating and progressive programme disseminating the most recent research in the field of neuromuscular conditions, this conference will provide an exciting poster session where up and coming researchers will have an opportunity to present their research to the neuromuscular community. For further details

2nd Pan-European Conference on Haemoglobinopathies

Date: 13-14 March 2010 Venue: Berlin, Germany This conference aims to further strengthen the national and regional support networks for thalassaemia patients in Europe, and increase awareness among European medical professionals and national health authorities of the disorder, its proper management and prevention. For further details

Document info
Document views46
Page views46
Page last viewedThu Jan 19 05:26:36 UTC 2017